Prescient Therapeutics LimitedASX: PTX

Appendix 4G and Corporate Governance Statement

· Issued by Prescient Therapeutics Limited via ASX

Filed with ASX ·

Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity Prescient Therapeutics Limited ABN/ARBN Financial year ended: 56 006 569 106 30 June...

View Attachment

6ix hasn’t read this filing yet.

Prescient Therapeutics Limited on 6ix

Earlier from Prescient Therapeutics

Later from Prescient Therapeutics

All Prescient Therapeutics news releases